Cited by 37Erythropoietin and Anemia TreatmentCancer, Hypoxia, and MetabolismHemoglobinopathies and Related Disorders

Two new mutations in the HIF2A gene associated with erythrocytosis

Open access
Percy, Melanie J., Chung, Yu Jin, Harrison, Claire, Mercieca, Jane, Hoffbrand, A. Victor, Dinardo, Carla L., Santos, Paulo C.J.L., Fonseca, Guilherme H.H. +5 more·2012·American Journal of Hematology

Abstract

Abstract Congenital or familial erythrocytosis/polycythemia can have many causes, and an emerging cause is genetic disruption of the oxygen‐sensing pathway that regulates the Erythropoietin (EPO) gene. More specifically, recent studies have identified erythrocytosis‐associated mutations in the HIF2A gene, which encodes for Hypoxia Inducible Factor‐2α (HIF‐2α), as well as in two genes that encode for proteins that regulate it, Prolyl Hydroxylase Domain protein 2 (PHD2) and the von Hippel Lindau tumor suppressor protein (VHL). We report here the identification of two new heterozygous HIF2A missense mutations, M535T, and F540L, both associated with erythrocytosis. Met‐535 has previously been identified as a residue mutated in other patients with erythrocytosis; although, the mutation of this particular residue to Thr has not been reported. In contrast, Phe‐540 has not been reported as a residue mutated in erythrocytosis, and we present evidence here that this mutation impairs interaction of HIF‐2α with both VHL and PHD2. Am. J. Hematol. 2012. © 2012 Wiley Periodicals, Inc.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajh.23123

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Most gain-of-function mutations in HIF-2α are in direct proximity to proline residue 531.

    “Most gain-of-function mutations in HIF-2α are in direct proximity to proline residue 531, which is one of the two main hydroxylation sites (the other major hydroxylation site is proline 405). 147–154”

    From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [154]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Percy, M. J., Chung, Y. J., Harrison, C., Mercieca, J., Hoffbrand, A. V., Dinardo, C. L., Santos, P. C. J. L., Fonseca, G. H. H., Gualandro, S. F. M., Pereira, A. C., Lappin, T. R. J., McMullin, M. F., & Lee, F. S.
Affiliations
  • Belfast City Hospital (GB)
  • University of Pennsylvania (US)
  • St Thomas' Hospital (GB)
  • St Helier Hospital (GB)
  • The Royal Free Hospital (GB)
  • Universidade de São Paulo (BR)
  • Queen's University Belfast (GB)
Corresponding author
Lee, Frank S.
Venue
American Journal of Hematology
Publisher
Wiley
Published
2012-02-24
Volume
87
Issue
4
Pages
439-442
ISSN
  • 0361-8609 (ISSN-L)
  • 1096-8652
OpenAlex
W1985535116
Cited by
37
References
25
Citations by year
2024: 2 · 2023: 1 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 5 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 3 · 2013: 8
FWCI
2.99
Type
journal article
Language
en
Open access
Locations
  • American Journal of Hematology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
  • Research Portal (Queen's University Belfast) (submittedVersion)
Funders
  • Universidade de São Paulo
  • National Cancer Institute (R01CA153347)
Topics
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
  • Health Sciences › Medicine › Genetics › Hemoglobinopathies and Related Disorders
Keywords
HIF-2α, erythrocytosis, familial erythrocytosis, missense mutations, PHD2, von Hippel-Lindau protein, protein-protein interaction, oxygen sensing, erythropoietin regulation, polycythemia
MeSH terms
Endothelial PAS Domain-Containing Protein 1, Adult, Amino Acid Sequence, Base Sequence, Erythropoietin, Exons, Female, Heterozygote, Humans, Male, Middle Aged, Molecular Sequence Data, Polycythemia, Procollagen-Proline Dioxygenase, Signal Transduction, Sequence Alignment, Conserved Sequence, Point Mutation, Sequence Homology, Amino Acid, Amino Acid Substitution, Mutation, Missense, Protein Interaction Mapping, Basic Helix-Loop-Helix Transcription Factors, Basic Helix-Loop-Helix Proteins, Von Hippel-Lindau Tumor Suppressor Protein, Hypoxia-Inducible Factor-Proline Dioxygenases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review